ClinConnect ClinConnect Logo
Search / Trial NCT06548516

Maxillary Labial Frenectomy: Diode Lasers Versus Surgical Scalpel

Launched by NECMETTIN ERBAKAN UNIVERSITY · Aug 7, 2024

Trial Information

Current as of August 24, 2025

Recruiting

Keywords

Maxillary Labial Frenum Frenectomy

ClinConnect Summary

This clinical trial is looking at two different methods for a dental procedure called a frenectomy, which is done to treat a high frenum attachment in the mouth. The researchers want to find out if using a diode laser for the surgery leads to less pain and better healing compared to the traditional method using a surgical scalpel. They are focusing on healthy adults aged 18-45 who don’t smoke and have certain dental conditions.

If you choose to participate, you will receive one of the two types of surgery and will get instructions on how to care for your mouth afterward. Your pain levels will be tracked over a few days, and your healing will be checked at different times after the procedure. To be eligible, you should have at least 20 teeth, not have had any periodontal treatment recently, and not have any serious health issues that might affect healing. This study is important because it could help improve methods for this common dental procedure, making it easier for patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Systemically healthy
  • Nonsmoker
  • No periodontal treatment received in the last 3 months
  • Having at least 20 teeth
  • Presence of at least central incisors, lateral incisors, and canines in the maxilla
  • Not pregnant or breastfeeding
  • No psychiatric, mental, or physical impairments
  • Diagnosed with gingival health based on the "World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions
  • Consent to participate in the study.
  • Exclusion Criteria:
  • Any systemic disease that could interfere with the wound healing process (e.g., diabetes mellitus and HIV infection)
  • Smoking
  • Use of antibiotics, anti-inflammatory drugs, or any other medication in the last 6 months that could affect the study's outcome
  • Any hypersensitivity reactions to paracetamol
  • Any physical limitations or restrictions that could impede normal oral hygiene procedures.

About Necmettin Erbakan University

Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.

Locations

Konya, , Turkey

Patients applied

0 patients applied

Trial Officials

zeynep taştan eroğlu

Principal Investigator

Necmettin Erbakan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported